Walgreens Boots Alliance’s (WBA) “Outperform” Rating Reiterated at Robert W. Baird

Walgreens Boots Alliance Inc (NASDAQ:WBA)‘s stock had its “outperform” rating reiterated by equities researchers at Robert W. Baird in a research report issued on Monday. They currently have a $96.00 price objective on the pharmacy operator’s stock. Robert W. Baird’s price objective would indicate a potential upside of 14.89% from the stock’s previous close.

A number of other equities research analysts have also recently weighed in on WBA. Leerink Swann set a $90.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Sunday, January 8th. Jefferies Group LLC reaffirmed a “buy” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a report on Friday, January 6th. Deutsche Bank AG set a $92.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Saturday, January 21st. Atlantic Securities raised Walgreens Boots Alliance from a “neutral” rating to an “overweight” rating and set a $95.00 target price on the stock in a report on Monday, February 6th. Finally, Evercore ISI reaffirmed a “buy” rating and set a $93.00 target price on shares of Walgreens Boots Alliance in a report on Tuesday, January 31st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and eleven have given a buy rating to the company. Walgreens Boots Alliance has a consensus rating of “Buy” and an average target price of $91.56.

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Shares of Walgreens Boots Alliance (NASDAQ:WBA) traded up 0.71% on Monday, hitting $83.56. 2,410,041 shares of the stock traded hands. The company’s 50 day moving average is $84.84 and its 200 day moving average is $83.05. The stock has a market cap of $90.20 billion, a price-to-earnings ratio of 22.11 and a beta of 1.20. Walgreens Boots Alliance has a one year low of $75.74 and a one year high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, January 5th. The pharmacy operator reported $1.10 earnings per share for the quarter, beating analysts’ consensus estimates of $1.09 by $0.01. Walgreens Boots Alliance had a net margin of 3.52% and a return on equity of 16.76%. The business had revenue of $28.50 billion for the quarter. During the same quarter in the prior year, the firm earned $1.03 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was down 1.8% compared to the same quarter last year. On average, equities analysts forecast that Walgreens Boots Alliance will post $5.00 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, March 10th. Investors of record on Wednesday, February 15th were paid a $0.375 dividend. The ex-dividend date of this dividend was Monday, February 13th. This represents a $1.50 dividend on an annualized basis and a yield of 1.80%. Walgreens Boots Alliance’s dividend payout ratio is currently 39.68%.

TRADEMARK VIOLATION NOTICE: This news story was reported by Mideast Time and is the property of of Mideast Time. If you are accessing this news story on another domain, it was stolen and republished in violation of international copyright and trademark laws. The original version of this news story can be read at https://www.mideasttime.com/walgreens-boots-alliances-wba-outperform-rating-reiterated-at-robert-w-baird/1589634.html.

In related news, COO Ornella Barra purchased 124,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 7th. The shares were purchased at an average price of $80.93 per share, with a total value of $10,035,320.00. Following the purchase, the chief operating officer now owns 1,690,336 shares of the company’s stock, valued at approximately $136,798,892.48. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Janice M. Babiak purchased 600 shares of the company’s stock in a transaction that occurred on Thursday, February 2nd. The stock was bought at an average cost of $80.68 per share, for a total transaction of $48,408.00. Following the purchase, the director now directly owns 600 shares in the company, valued at approximately $48,408. The disclosure for this purchase can be found here. Company insiders own 13.50% of the company’s stock.

Large investors have recently made changes to their positions in the company. Price T Rowe Associates Inc. MD raised its stake in shares of Walgreens Boots Alliance by 35.1% in the third quarter. Price T Rowe Associates Inc. MD now owns 39,319,406 shares of the pharmacy operator’s stock worth $3,169,931,000 after buying an additional 10,206,621 shares during the last quarter. Norges Bank acquired a new stake in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $649,813,000. Nordea Investment Management AB raised its stake in shares of Walgreens Boots Alliance by 4,480.8% in the third quarter. Nordea Investment Management AB now owns 7,453,892 shares of the pharmacy operator’s stock worth $600,933,000 after buying an additional 7,291,172 shares during the last quarter. Viking Global Investors LP raised its stake in shares of Walgreens Boots Alliance by 562.8% in the fourth quarter. Viking Global Investors LP now owns 7,899,951 shares of the pharmacy operator’s stock worth $653,800,000 after buying an additional 6,708,040 shares during the last quarter. Finally, Lazard Asset Management LLC raised its stake in shares of Walgreens Boots Alliance by 138.3% in the third quarter. Lazard Asset Management LLC now owns 7,680,077 shares of the pharmacy operator’s stock worth $619,166,000 after buying an additional 4,457,421 shares during the last quarter. Hedge funds and other institutional investors own 59.98% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.